Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

653
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
653
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.6K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.6K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

92
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
92

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world outcomes of Axicabtagene Ciloleucel CAR-T therapy in large B-cell lymphoma: a single-center observational study.

Cytotherapy·2026
Same author

Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag.

NEJM evidence·2026
Same author

Umbilical cord blood transplantation in children with Diamond-Blackfan anemia.

Bone marrow transplantation·2026
Same author

HLH and spinal neurofibroma: a single case report in a patient with DiGeorge syndrome.

Frontiers in oncology·2026
Same author

American Society of Hematology 2026 Guidelines for the Diagnosis and Management of Severe Acquired Aplastic Anemia.

Blood advances·2026
Same author

Retrospective Analysis of Incidence and Etiology of Severe Infections in Children Receiving Therapy for High-Risk Neuroblastoma: A Large Single-Center Experience.

Pediatric blood & cancer·2026

Related Experiment Video

Updated: Nov 30, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.8K

Hepatitis-Associated Aplastic Anemia.

Alfadel Alshaibani1, Carlo Dufour2, Antonio Risitano3

  • 1King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Hematology/Oncology and Stem Cell Therapy
|November 16, 2020
PubMed
Summary

Hepatitis-associated aplastic anemia (HAAA) is a rare, potentially fatal condition causing pancytopenia. Immune destruction of stem cells is the suspected cause, requiring immunosuppression or stem cell transplantation for treatment.

More Related Videos

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.5K
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.7K

Related Experiment Videos

Last Updated: Nov 30, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.8K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.5K
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.7K

Area of Science:

  • Hematology
  • Hepatology
  • Immunology

Background:

  • Hepatitis-associated aplastic anemia (HAAA) is a rare condition.
  • It presents as pancytopenia with hypoplastic bone marrow.
  • HAAA occurs in 1-5% of acquired aplastic anemia cases.

Purpose of the Study:

  • To summarize the key aspects of Hepatitis-associated aplastic anemia.
  • To highlight the pathophysiology and management of HAAA.

Main Methods:

  • Literature review of Hepatitis-associated aplastic anemia.
  • Analysis of clinical presentation, pathophysiology, and treatment modalities.

Main Results:

  • HAAA is characterized by pancytopenia and hypoplastic bone marrow.
  • Onset typically occurs within 6 months of elevated serum aminotransferases.
  • While several hepatitis viruses are implicated, many cases remain idiopathic.
  • Immune-mediated destruction of hematopoietic stem cells is the presumed mechanism.
  • HAAA is a life-threatening condition if untreated.

Conclusions:

  • Hepatitis-associated aplastic anemia necessitates prompt management.
  • Treatment options include immunosuppression (antithymocyte globulin, cyclosporine) and allogeneic hematopoietic stem cell transplantation.